Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial

Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial

Background: Poor adherence to medications is a global public health concern with substantial health and cost implications, especially for chronic conditions. In the USA, poor adherence is estimated to cause 125,000 deaths and cost

Bibliographic Details
Main Authors: Bilger, M. (Author), Bundoc, F.G (Author), Finkelstein, E.A (Author), Howard, K.L (Author), Lamoureux, E.L (Author), Lee, J.Y (Author), Wong, T.T (Author)
Format: Article
Language:English
Published: Adis 2019
Subjects:
adherence contingent rebate
adult
Adult
aged
Aged
Aged, 80 and over
antiglaucoma agent
Article
behavioral economics
chronic disease
Chronic Disease
controlled study
cost effectiveness analysis
Drug Therapy
economics
eye drops
female
Female
glaucoma
Glaucoma
human
Humans
major clinical study
male
Male
Medication Adherence
medication compliance
middle aged
Middle Aged
open study
parallel design
patient compliance
randomized controlled trial
reimbursement
Reimbursement, Incentive
treatment duration
very elderly
young adult
Young Adult
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items